Athira Pharma, Inc. - Common Stock (ATHA)
0.5253
-0.0087 (-1.63%)
Athira Pharma Inc is a biotechnology company dedicated to developing innovative therapies for neurological diseases
It focuses on harnessing the body's natural neurorepair processes to create treatments aimed at improving cognitive function and addressing conditions such as Alzheimer's disease and other forms of dementia. Through advanced research and clinical trials, Athira aims to provide new hope for patients and their families by unlocking the potential of molecular and cellular mechanisms in the brain. The company's commitment to scientific excellence drives its mission of advancing treatments that may enhance the quality of life for those affected by these challenging conditions.
Frequently Asked Questions
Is Athira Pharma, Inc. - Common Stock publicly traded?
Yes, Athira Pharma, Inc. - Common Stock is publicly traded.
What exchange does Athira Pharma, Inc. - Common Stock trade on?
Athira Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Athira Pharma, Inc. - Common Stock?
The ticker symbol for Athira Pharma, Inc. - Common Stock is ATHA on the Nasdaq Stock Market
What is the current price of Athira Pharma, Inc. - Common Stock?
The current price of Athira Pharma, Inc. - Common Stock is 0.5253
When was Athira Pharma, Inc. - Common Stock last traded?
The last trade of Athira Pharma, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Athira Pharma, Inc. - Common Stock?
The market capitalization of Athira Pharma, Inc. - Common Stock is 19.99M
How many shares of Athira Pharma, Inc. - Common Stock are outstanding?
Athira Pharma, Inc. - Common Stock has 38.05M shares outstanding.